Literature DB >> 4011073

Prospective randomized study of x-ray pelvimetry in the primigravida.

M T Parsons, W N Spellacy.   

Abstract

A prospective randomized study was performed to determine the usefulness of x-ray pelvimetry before oxytocin induction or augmentation. Two hundred primiparous women were entered into this study. Agreement on pelvic size by the clinical and radiologic assessment occurred in 76.5% of the cases. When the total groups were compared, there were no differences in pregnancy outcome. In the induction of labor subgroups there were less forcep deliveries and lower five-minute Apgar scores in the pelvimetry group. In the augmentation subgroups there were no differences. The subgroup of patients diagnosed clinically to have a borderline pelvis, had a higher incidence of cesarean section (P less than .05) if they had x-ray pelvimetry. These results suggest that the elimination of x-ray pelvimetry in primigravida women does not lead to a compromise in infant outcome when electronic fetal monitoring is used.

Entities:  

Mesh:

Year:  1985        PMID: 4011073

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Reducing stillbirths: screening and monitoring during pregnancy and labour.

Authors:  Rachel A Haws; Mohammad Yawar Yakoob; Tanya Soomro; Esme V Menezes; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

Review 2.  Pelvimetry for fetal cephalic presentations at or near term for deciding on mode of delivery.

Authors:  Robert C Pattinson; Anna Cuthbert; Valerie Vannevel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-30

3.  Erect lateral pelvimetry and the outcome of labor in Lagos.

Authors:  O K Ogedengbe; O Okikiolu; R I Macrae; O F Giwa-Osagie
Journal:  J Natl Med Assoc       Date:  1993-01       Impact factor: 1.798

4.  Radiographic measures of the mid pelvis to predict cesarean delivery.

Authors:  Lorie M Harper; Anthony O Odibo; David M Stamilio; George A Macones
Journal:  Am J Obstet Gynecol       Date:  2013-03-01       Impact factor: 8.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.